Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21423238rdf:typepubmed:Citationlld:pubmed
pubmed-article:21423238lifeskim:mentionsumls-concept:C0687133lld:lifeskim
pubmed-article:21423238pubmed:issue4lld:pubmed
pubmed-article:21423238pubmed:dateCreated2011-3-22lld:pubmed
pubmed-article:21423238pubmed:abstractTextTransporters are membrane-bound proteins that control the access of endogenous and xenobiotics (drugs) to various sites in the human body. They influence drug pharmacokinetics and pharmacodynamics (both benefit and risk) by affecting a drug's absorption, distribution, metabolism (via control of access to metabolizing enzymes), and excretion (ADME) and by controlling drug concentrations at the site of action. Like metabolizing enzymes, transporters have binding sites that are saturable and can be inhibited or induced.lld:pubmed
pubmed-article:21423238pubmed:languageenglld:pubmed
pubmed-article:21423238pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21423238pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21423238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21423238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21423238pubmed:statusMEDLINElld:pubmed
pubmed-article:21423238pubmed:monthAprlld:pubmed
pubmed-article:21423238pubmed:issn1532-6535lld:pubmed
pubmed-article:21423238pubmed:authorpubmed-author:LeskoL JLJlld:pubmed
pubmed-article:21423238pubmed:authorpubmed-author:ZhangLLlld:pubmed
pubmed-article:21423238pubmed:authorpubmed-author:HuangS-MSMlld:pubmed
pubmed-article:21423238pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21423238pubmed:volume89lld:pubmed
pubmed-article:21423238pubmed:ownerNLMlld:pubmed
pubmed-article:21423238pubmed:authorsCompleteYlld:pubmed
pubmed-article:21423238pubmed:pagination481-4lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:meshHeadingpubmed-meshheading:21423238...lld:pubmed
pubmed-article:21423238pubmed:year2011lld:pubmed
pubmed-article:21423238pubmed:articleTitleTransporter-mediated drug-drug interactions.lld:pubmed
pubmed-article:21423238pubmed:affiliationOffice of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. leik.zhang@fda.hhs.govlld:pubmed
pubmed-article:21423238pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21423238pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed